@drpatriciorey Con respecto a la farmacología, a mí me bajó un poco la moral esta revisión sistemática del grupo Cochrane (2022): https://t.co/CxecHkY8Kd Sin embargo creo que los fármacos pueden auxiliar a la psicoterapia como tratamientos sintomáticos; e
RT @CochraneJapan: 境界性パーソナリティ障害をもつ人に対する薬物療法の利益とリスクは何か? https://t.co/ax5mMmdTXb
境界性パーソナリティ障害をもつ人に対する薬物療法の利益とリスクは何か? What are the benefits and risks of medication for people with borderline personality disorder? #CochraneJapan #Cochrane https://t.co/PTm7z52WQR
RT @CochraneJapan: 境界性パーソナリティ障害をもつ人に対する薬物療法の利益とリスクは何か? https://t.co/ax5mMmdTXb
境界性パーソナリティ障害をもつ人に対する薬物療法の利益とリスクは何か? https://t.co/ax5mMmdTXb
RT @paulmcau: “Compared with placebo, medications seem to make little to no difference to BPD [borderline personality disorder] severity, s…
RT @paulmcau: “Compared with placebo, medications seem to make little to no difference to BPD [borderline personality disorder] severity, s…
“Compared with placebo, medications seem to make little to no difference to BPD [borderline personality disorder] severity, self-harm, suicide-related outcomes, and psychosocial functioning.” Jutta Stoffers-Winterling et al via @cochranecollab https://t.co
What are the benefits and risks of medication for people with borderline personality disorder? https://t.co/pUQWz4gJ23
I know what I do in my daily practice. It's everyone's responsibility to ensure we are providing the best evidence based care/ interventions. Have the difficult conversation, it's what will be the most helpful. (3/3) https://t.co/wGCBJud3Lz
『人格障害っていう名前だけど、数多くの傷付きが背景にあるっていう人々。何よりも、支えることが重要なんだなぁ』
RT @SEdwardsNHS: Details of an update to this Cochrane Review: Pharmacological interventions for people with borderline personality disorde…
Details of an update to this Cochrane Review: Pharmacological interventions for people with borderline personality disorder https://t.co/RKtDpYQezi
In borderline personality, meds help comorbidities like depression/bipolar, but they don’t address core #bpd symptoms, concludes this meticulous update from the Cochrane group. #Psychiatry https://t.co/6ruAL8e1rh https://t.co/YaXX0qsxkC
RT @CochraneDPLP: New review published on 'Pharmacological interventions for people with borderline personality disorder'. Read it on @Coch…
🚨Important review for #mentalhealth clinicians showing lack of evidence for pharmacological BPD management. Risks associated with low-dose antipsychotics particularly concerning given accumulating evidence that many cardiometabolic s/e are dose-independent
Cliff notes, nothing works
RT @CochraneDPLP: New review published on 'Pharmacological interventions for people with borderline personality disorder'. Read it on @Coch…
RT @PratiqueAvancee: Interventions pharmacologiques pour les personnes atteintes d'un trouble de la personnalité borderline @CochraneFrance…
Interventions pharmacologiques pour les personnes atteintes d'un trouble de la personnalité borderline @CochraneFrance https://t.co/2D7XCtdoHY
Intervenciones psicofarmacologicas para personas con diagnostico de Trastorno Límite de la Personalidad https://t.co/fdfuUOHcZT
Pharmacological interventions for people with borderline personality disorder @cochranecollab https://t.co/ibhUVtg62a
Pharmacological interventions for people with borderline personality disorder - Stoffers-Winterling, JM - 2022 | Cochrane Library https://t.co/XTIhJZ8FVB
RT @tkaiser_science: "The review supports the continued understanding that no pharmacological therapy seems effective in specifically treat…
RT @tkaiser_science: "The review supports the continued understanding that no pharmacological therapy seems effective in specifically treat…
"The review supports the continued understanding that no pharmacological therapy seems effective in specifically treating BPD pathology." https://t.co/Vofb3fHPS6
Our new review an pharmacological interventions for borderline PD https://t.co/v0z8iJpeMO
Pharmacological interventions for people with borderline personality disorder (review, 2022): The review supports the continued understanding that no pharmacological therapy seems effective in specifically treating BPD pathology. https://t.co/ZYoNDV1mYZ
Vores nye Cochrane review er blevet publiceret idag https://t.co/3FRQdDzPtd